This inventor holds 17 USPTO granted patents and 2 EPO patents, primarily in Kinase Inhibitors. Top assignees: Smithkline Beecham Corporation, Glaxo Group Limited, Sunesis Pharmaceuticals, Inc.. Active years: 1998-2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- San Mateo, CA (US) (2002 - 2003)
- Foster City, CA (US) (2003)
- Swarthmore, PA (US) (1998 - 2005)
- Swathmore, PA (US) (2003 - 2007)
- King of Prussia, PA (US) (2008 - 2009)
Company Filing History:
14 out of 2,198 
2 out of 1,170 
1 out of 63 
Years Active: 1998-2009
Areas of Expertise:
Title: The Innovative Contributions of Dennis Lee
Introduction
Dennis Lee is a prominent inventor based in San Mateo, CA. He has made significant contributions to the field of medicinal chemistry, holding a total of 17 patents. His work primarily focuses on developing novel compounds that target specific kinases, which are crucial in various biological processes.
Latest Patents
Among his latest patents, Dennis Lee has disclosed compounds that serve as novel inhibitors of Rho-kinases. Additionally, he has developed indazolo-tetrahydropyrimidine-carboxamide derivative kinase inhibitors. This invention relates to the derivatives, compositions, and medicaments that contain these compounds, as well as the processes for their preparation and use. These indazolo-tetrahydropyrimidine-carboxamide derivatives are particularly useful in treating diseases associated with inappropriate ROCK-1 kinase activity.
Career Highlights
Throughout his career, Dennis Lee has worked with notable companies such as SmithKline Beecham Corporation and Glaxo Group Limited. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in the pharmaceutical industry.
Collaborations
Dennis has collaborated with several professionals in his field, including Jerry Leroy Adams and Krista B Goodman. These partnerships have facilitated the exchange of ideas and fostered innovation in his projects.
Conclusion
Dennis Lee's innovative work in developing kinase inhibitors has the potential to impact the treatment of various diseases significantly. His contributions to medicinal chemistry and collaboration with esteemed colleagues highlight his dedication to advancing scientific knowledge.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile